Cargando…
Albumin-binding tag derived Exendin-4 analogue for treating hyperglycemia and diabetic complications
Current study was conducted to design and screen a long-lasting Exendin-4 analog for treating type 2 diabetes via the novel strategy of albumin binding combined with thrombin enzymolysis. First, a series of fusion peptides, containing different albumin-binding tags, a determinate thrombin-cleavable...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974032/ https://www.ncbi.nlm.nih.gov/pubmed/34696658 http://dx.doi.org/10.1080/21655979.2021.1995993 |